References
Winkler K, Beron G, Delling G (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337
el Nakadi B, Nouwynck C, Salhadin A (1995) Combined therapeutic approach for extraorbital sebaceous carcinoma in a Torre’s syndrome. Eur J Surg Oncol 21:321–322
Russell HC, Chadha V, Lockington D, Kemp EG (2010) Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol 94:1316–1321
Husain A, Blumenschein G, Esmaeli B (2008) Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol 47:276–279
Murthy R, Honavar SG, Burman S, Vemuganti GK, Naik MN, Reddy VA (2005) Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis. Ophthal Plast Reconstr Surg 21:307–309
Priyadarshini O, Biswas G, Biswas S, Padhi R, Rath S (2010) Neoadjuvant chemotherapy in recurrent sebaceous carcinoma of eyelid with orbital invasion and regional lymphadenopathy. Ophthal Plast Reconstr Surg 26:366–368
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gogia, A., Pushker, N., Sen, S. et al. Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvant chemotherapy. Graefes Arch Clin Exp Ophthalmol 251, 2479–2480 (2013). https://doi.org/10.1007/s00417-013-2382-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2382-8